Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. NeutriSci International Inc.
  6. News
  7. Summary
    NU   CA64129Y1079

NEUTRISCI INTERNATIONAL INC.

(NU)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

NEUTRISCI INTERNATIONAL : RELEASES UPDATE REGARDING PRODUCT LAUNCH IN CALIFORNIA

08/12/2020 | 12:18pm EDT

Vancouver, British Columbia - August 12, 2020 - NeutriSci International Inc. ('NeutriSci' or the 'Company') (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that Cryopharm Corp. ('Cryopharm' - www.cryopharm.com), its US manufacturing and distribution partner; will begin the distribution of NeutriSci's and Cryopharm's CBD & THC products into more than 90 dispensaries across Southern California the last week of August 2020. The distribution is expected to grow to over 350 dispensaries in Q4/2020.

NeutriSci's Zenstix™ and Kushtabs™, quick melting tabs activate faster when compared to other cannabis edibles with a powerful and maximum allowable 10mg dose. Each stick contains 6 tablets in a child-resistant package. This calorie and sugar-free product comes in three flavors (Lemon Lime, Iced Pomegranate and Raspberry Lemonade).

Cryopharm's Marbl Melts™ represent an industry-first cannabis infused product; flavorful, micro dosed, rapidly dissolvable oral melts infused with THC & CBD. NeutriSci's core ingredients form the basis of Marbl Melts™, containing a clinically tested dosage providing on-set in as little as 12 minutes; compared to traditional cannabinoid infusion methods that often have incorrect dosages that can potentially take up to 120 minutes to become active. Marbl Melts™ are available in several unique offerings designed for specific uses such as sleep, energy, relaxation. Glen Rehman, CEO of NeutriSci, stated: 'Despite limited and reduced accessibility due to COVID-19, the California manufacturing facility has been able to gradually increase its production capacity to meet initial demands. Cryopharm has also been able to work with its network of distributors to secure initial orders and begin the distribution of the Zenstix and Kushtabs into Northern California as early as August 27th.'

'Despite these trying and difficult times, we have been able to further the business and increase the growth potential by expanding our partner relationships. With the start of distribution in California, NeutriSci will not only generate substantial revenue from our own line of THC products but we will also be realizing new revenue streams from licence partners like Cryopharm. While we continue to push forward in the tough US climate, we are grateful that we made great progress in other parts of the world like Japan. Our global business model has opened opportunities around the world; helping to insulate us from potential regional slowdowns helping to maintain our internal sales targets, reach profitability and increase shareholder value', he added.

NEUTRISCI INTERNATIONAL INC.
Glen Rehman
CEO
Tel: (403) 264-6320

For investor inquiries, please contact investors@neutrisci.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company's natural energy and focus supplement that has at its core, the beneficial effects of blueberries.

Neuenergy® contains a unique patented combination of blueberry extract (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit www.getneuenergy.com.

For more information, please visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Disclaimer

NeutriSci International Inc. published this content on 12 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2020 16:17:07 UTC


© Publicnow 2020
All news about NEUTRISCI INTERNATIONAL INC.
09/10NEUTRISCI INTERNATIONAL : Raises C$276,550 in Private Placement, Warrant Exercis..
MT
09/10NeutriSci International Inc. announced that it expects to receive CAD 0.03155..
CI
08/27Neutrisci International Inc. Reports Earnings Results for the Second Quarter ..
CI
08/12Neutrisci International Inc. Provides Update on Tabletz Developments
CI
08/12NEUTRISCI INTERNATIONAL INC :
AQ
07/19NEUTRISCI INTERNATIONAL INC.(TSXV : NU) dropped from S&P/TSX Venture Composite I..
CI
07/08NEUTRISCI INTERNATIONAL : Provides Update on Tabletz and Previously Announced Pr..
PU
07/07Neutrisci International Inc. Provides Update on Tabletz and Project Developme..
CI
06/23NEUTRISCI INTERNATIONAL : Provides Update On Biople Product Launch In Japan
PU
06/09UPDATE : Neutrisci Rises 6% in Canada Trading on Shipment of Tabletz Rush Order ..
MT
More news
Financials
Sales 2020 0,07 M 0,06 M 0,06 M
Net income 2020 -1,95 M -1,53 M -1,53 M
Net cash 2020 0,01 M 0,01 M 0,01 M
P/E ratio 2020 -9,55x
Yield 2020 -
Capitalization 14,5 M 11,4 M 11,4 M
EV / Sales 2019 31,7x
EV / Sales 2020 261x
Nbr of Employees -
Free-Float 100%
Chart NEUTRISCI INTERNATIONAL INC.
Duration : Period :
NeutriSci International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Glen Rehman President, Chief Executive Officer & Director
John Robert Chisholm Chief Financial Officer
Jeff Durno Chairman
Jaycee Waters Manager-Operations & Logistics
Anthony Hugens Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NEUTRISCI INTERNATIONAL INC.-30.77%11
BY-HEALTH CO., LTD.7.45%6 833
HERBALIFE NUTRITION LTD.-10.93%4 519
BALCHEM CORPORATION20.16%4 482
THE SIMPLY GOOD FOODS COMPANY11.54%3 350
MEDIFAST, INC.11.44%2 519